407 related articles for article (PubMed ID: 17048291)
1. The oriented development of antituberculotics: salicylanilides.
Waisser K; Matyk J; Divisová H; Husáková P; Kunes J; Klimesová V; Kaustová J; Möllmann U; Dahse HM; Miko M
Arch Pharm (Weinheim); 2006 Nov; 339(11):616-20. PubMed ID: 17048291
[TBL] [Abstract][Full Text] [Related]
2. The oriented development of antituberculotics (Part II): halogenated 3-(4-alkylphenyl)-1,3-benzoxazine-2,4-(3H)-diones.
Waisser K; Matyk J; Divisová H; Husáková P; Kunes J; Klimesová V; Palát K; Kaustová J
Arch Pharm (Weinheim); 2007 May; 340(5):264-7. PubMed ID: 17516578
[TBL] [Abstract][Full Text] [Related]
3. Highly active antimycobacterial derivatives of benzoxazine.
Petrlíková E; Waisser K; Divišová H; Husáková P; Vrabcová P; Kuneš J; Kolář K; Stolaříková J
Bioorg Med Chem; 2010 Dec; 18(23):8178-87. PubMed ID: 21044844
[TBL] [Abstract][Full Text] [Related]
4. N-benzylsalicylthioamides: highly active potential antituberculotics.
Dolezal R; Waisser K; Petrlíková E; Kunes J; Kubicová L; Machácek M; Kaustová J; Dahse HM
Arch Pharm (Weinheim); 2009 Feb; 342(2):113-9. PubMed ID: 19137534
[TBL] [Abstract][Full Text] [Related]
5. Relationship between the structure and antimycobacterial activity of substituted salicylanilides.
Waisser K; Bures O; Holý P; Kunes J; Oswald R; Jirásková L; Pour M; Klimesová V; Kubicová L; Kaustová J
Arch Pharm (Weinheim); 2003 Mar; 336(1):53-71. PubMed ID: 12666254
[TBL] [Abstract][Full Text] [Related]
6. [Relation between chemical structure and antimycobacterial activity against atypical strains. XIII. Thiosalicylanilides].
Waisser K; Kubicová L; Gregor J; Budová J; Andrlová A; Drsata J; Odlerová Z
Ceska Slov Farm; 1998 Mar; 47(2):84-6. PubMed ID: 9650366
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antimycobacterial evaluation of N-substituted 3-aminopyrazine-2,5-dicarbonitriles.
Zitko J; Jampílek J; Dobrovolný L; Svobodová M; Kuneš J; Doležal M
Bioorg Med Chem Lett; 2012 Feb; 22(4):1598-601. PubMed ID: 22281187
[TBL] [Abstract][Full Text] [Related]
8. A duplicated nitrotienyl derivative with antimycobacterial activity: synthesis, X-ray crystallography, biological and mutagenic activity tests.
Rando DG; Doriguetto AC; Tomich de Paula da Silva CH; Ellena J; Sato DN; Leite CQ; Varanda EA; Ferreira EI
Eur J Med Chem; 2006 Oct; 41(10):1196-200. PubMed ID: 16828526
[TBL] [Abstract][Full Text] [Related]
9. New antituberculotics originated from salicylanilides with promising in vitro activity against atypical mycobacterial strains.
Imramovský A; Vinsová J; Férriz JM; Dolezal R; Jampílek J; Kaustová J; Kunc F
Bioorg Med Chem; 2009 May; 17(10):3572-9. PubMed ID: 19403314
[TBL] [Abstract][Full Text] [Related]
10. Highly active potential antituberculotics: 3-(4-alkylphenyl)-4-thioxo-2H-1,3-benzoxazine-2(3H)-ones and 3-(4-alkylphenyl)-2H-1,3-benzoxazine-2,4(3H)-dihiones substituted in ring-B by halogen.
Waisser K; Matyk J; Kunes J; Dolezal R; Kaustová J; Dahse HM
Arch Pharm (Weinheim); 2008 Dec; 341(12):800-3. PubMed ID: 19006090
[TBL] [Abstract][Full Text] [Related]
11. [New groups of potential antitubercular agents: 3-(4-ethoxythiocarbonylphenyl)-2-H-benzoxazin-2,4(3H)-diones and 3-(4-ethoxythiocarbonylphenyl)-4-thioxy-2H-benzoxazin-2(3H)-ones].
Waisser K; Holý P; Bures O; Kunes J; Kaustová J
Ceska Slov Farm; 2003 Jan; 52(1):42-7. PubMed ID: 12685334
[TBL] [Abstract][Full Text] [Related]
12. Salicylanilide carbamates: antitubercular agents active against multidrug-resistant Mycobacterium tuberculosis strains.
Férriz JM; Vávrová K; Kunc F; Imramovský A; Stolaríková J; Vavríková E; Vinsová J
Bioorg Med Chem; 2010 Feb; 18(3):1054-61. PubMed ID: 20060303
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antimycobacterial activity of some 4-pyridinecarboxyamidrazone derivatives.
Mamolo MG; Vio L; Banfi E; Predominato M; Fabris C; Asaro F
Farmaco; 1993 Apr; 48(4):529-38. PubMed ID: 8357468
[TBL] [Abstract][Full Text] [Related]
14. Antimycobacterial assessment of Salicylanilide benzoates including multidrug-resistant tuberculosis strains.
Krátký M; Vinšová J; Stolaříková J
Molecules; 2012 Oct; 17(11):12812-20. PubMed ID: 23114617
[TBL] [Abstract][Full Text] [Related]
15. [Antimicrobial salicylanilides and 3-phenyl-2H-1,3-benzoxazine-2,4(3H)-diones].
Waisser K; Gregor J; Holý P; Kubicová L; Klimesová V; Kaustová J
Ceska Slov Farm; 2001 May; 50(3):148-52. PubMed ID: 11394023
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antimycobacterial activity of 2-substituted halogenobenzimidazoles.
Kazimierczuk Z; Andrzejewska M; Kaustova J; Klimesova V
Eur J Med Chem; 2005 Feb; 40(2):203-8. PubMed ID: 15694655
[TBL] [Abstract][Full Text] [Related]
17. A new group of potential antituberculotics: hydrochlorides of piperidinylalkyl esters of alkoxy-substituted phenylcarbamic acids.
Waisser K; Drazková K; Cizmárik J; Kaustová J
Folia Microbiol (Praha); 2004; 49(3):265-8. PubMed ID: 15259766
[TBL] [Abstract][Full Text] [Related]
18. New S-benzylisothiosemicarbazones with antimycobacterial activity.
Petrlíková E; Waisser K; Heinisch L; Stolaříková J
Folia Microbiol (Praha); 2011 Jan; 56(1):10-2. PubMed ID: 21394476
[TBL] [Abstract][Full Text] [Related]
19. Anti-tubercular agents. Part 3. Benzothiadiazine as a novel scaffold for anti-Mycobacterium activity.
Kamal A; Reddy KS; Ahmed SK; Khan MN; Sinha RK; Yadav JS; Arora SK
Bioorg Med Chem; 2006 Feb; 14(3):650-8. PubMed ID: 16203154
[TBL] [Abstract][Full Text] [Related]
20. Antimycobacterial and antifungal isosters of salicylamides.
Waisser K; Pesina M; Holý P; Pour M; Bures O; Kunes J; Klimesová V; Buchta V; Kubanová P; Kaustová J
Arch Pharm (Weinheim); 2003 Aug; 336(6-7):322-35. PubMed ID: 12953220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]